Does the National Health Insurance Card Allow us to Predict Antibiotic Resistance?
1 other identifier
observational
1,128
1 country
2
Brief Summary
The objective is to determine if data from the National Insurance Health card (giving antibiotics and hospitalizations in the past 18 months) allow to predict the individual risk of antibiotic resistance and to identify population groups for which probabilistic antibiotics regimen of urinary tract infection could be simplified
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2015
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 20, 2014
CompletedFirst Posted
Study publicly available on registry
November 17, 2014
CompletedStudy Start
First participant enrolled
September 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2017
CompletedApril 16, 2026
April 1, 2026
1.4 years
October 20, 2014
April 13, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Frequency of antibiotic resistant organisms
Frequency of antibiotic resistant organisms in patient with urinary infection
One year
Eligibility Criteria
Patient with an community-acquired urinary tract infection
You may qualify if:
- national health insurance card available
- community acquired urinary tract infection
You may not qualify if:
- incapacity to accept an inform consent
- hospitalized acquired urinary tract infection
- national health insurance card non available
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Lbmr de Normandie
Elbeuf, France
Rouen University Hospital
Rouen, 76031, France
Related Publications (3)
Alexandre K, Reveillon-Istin M, Fabre R, Delbos V, Etienne M, Pestel-Caron M, Dahyot S, Caron F. Temocillin against Enterobacteriaceae isolates from community-acquired urinary tract infections: low rate of resistance and good accuracy of routine susceptibility testing methods. J Antimicrob Chemother. 2018 Jul 1;73(7):1848-1853. doi: 10.1093/jac/dky101.
PMID: 29635629RESULTAlexandre K, Gillibert A, Dahyot S, Fabre R, Kuhn F, Benichou J, Delbos V, Caron F. Individual health insurance data of antibiotic delivery in previous months as a tool to predict bacterial resistance of urinary tract infection: A prospective cohort study. Infect Dis Now. 2024 Sep;54(6):104942. doi: 10.1016/j.idnow.2024.104942. Epub 2024 Jun 25.
PMID: 38936476RESULTVautrin N, Dahyot S, Leoz M, Caron F, Grand M, Feldmann A, Gravey F, Legris S, Ribet D, Alexandre K, Pestel-Caron M. Are Escherichia coli causing recurrent cystitis just ordinary uropathogenic E. coli (UPEC) strains? Virulence. 2025 Dec;16(1):2444689. doi: 10.1080/21505594.2024.2444689. Epub 2024 Dec 26.
PMID: 39726097RESULT
Study Officials
- PRINCIPAL INVESTIGATOR
Francois CARON, Pr
UH Rouen
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 20, 2014
First Posted
November 17, 2014
Study Start
September 1, 2015
Primary Completion
February 1, 2017
Study Completion
February 1, 2017
Last Updated
April 16, 2026
Record last verified: 2026-04